{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9065941",
  "DateCompleted": {
    "Year": "1997",
    "Month": "05",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "02",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0030-3755",
      "JournalIssue": {
        "Volume": "211 Suppl 1",
        "PubDate": {
          "Year": "1997"
        }
      },
      "Title": "Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde",
      "ISOAbbreviation": "Ophthalmologica"
    },
    "ArticleTitle": "Prophylactic use of topical anti-infectives in ophthalmology.",
    "Pagination": {
      "StartPage": "68",
      "EndPage": "76",
      "MedlinePgn": "68-76"
    },
    "Abstract": {
      "AbstractText": [
        "The prophylactic use of topical anti-infectives is indicated on the eye (1) prior to any surgery on the eye, by periorbital and conjunctival administration and, if required, intraoperatively as well; (2) in the form of the Cred\u00e9 prophylaxis against ophthalmia neonatorum; (3) with accidental pathogenic contamination of the eye; (4) to prevent conjunctivitis by intensive care surgical patients; (5) for the antiseptic irrigation of donor bulbi prior to keratoplasty, and (6) if required, to prevent ocular infection in a given epidemiological situation. The drug of first choice is polyvinylpyrrolidone-iodine at a concentration ranging from 1.5 to 5%. Another topical anti-infective is a 0.02 or 0.01% solution of polyhexanide, a promising medication, currently in the process of being approved."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Hygiene and Environmental Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany."
          }
        ],
        "LastName": "Kramer",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Behrens-Baumann",
        "ForeName": "W",
        "Initials": "W"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Ophthalmologica",
    "NlmUniqueID": "0054655",
    "ISSNLinking": "0030-3755"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ophthalmic Solutions"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibiotic Prophylaxis"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Eye Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ophthalmic Solutions"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Postoperative Complications"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Preoperative Care"
    }
  ],
  "NumberOfReferences": "43"
}